Publications

Journal Article Epublish
Electronic publication date
February 14, 2025

View on Pubmed.gov 39948453 | View on doi.org 10.1186/s12880-...

Mapping the distribution of radial artery atherosclerosis by optical coherence tomography.

Search for publications in this journal BMC Med Imaging - 25(1):47

Abstract

BACKGROUND

Radial artery plaque (RAP) can influence the function of arterial conduits after revascularization and hinder the maturation of arteriovenous fistulas in patients undergoing hemodialysis patients. However, the preferred in vivo sites for RAP development have not been systematically investigated. This study measured and evaluated RAP to map the distribution of RAP in the radial artery (RA) using optical coherence tomography (OCT).

METHODS

OCT images of the entire RA in 300 patients at 1 mm intervals were analyzed to assess RAP phenotypes and measure the distance of RAP from the radial artery ostium. The RA was evenly divided into three segments: proximal, middle, and distal. Patients were categorized into two groups: the RAP group (n = 68) and the non-RAP group (n = 232).

RESULTS

Among the 300 patients with 300 radial arteries studied, 68 patients (22.7%) developed 180 distinct RAPs. The distal segment was the most susceptible to RAP formation (51 patients; 17.0%).In plaque level analysis, Most RAPs (55%) were located ≥ 150 mm from the RA ostium. The distal segment exhibited a significantly higher median cumulative plaque index compared with the proximal and middle segments (p = 0.031). Logistic regression analysis identified aging, smoking, diabetes mellitus, and multi-vessel coronary disease (MVCD) as independent risk factors for RAP occurrence.

CONCLUSIONS

RAP was observed in 22.7% of patients with acute coronary syndrome (ACS), with a predominant localization in the distal segment, both at the patient and plaque level. Significant risk factors included aging, smoking, diabetes mellitus, and MVCD.

References

Rev Cardiovasc Med. 2022 Jan 20;23(1):39

Postepy Kardiol Interwencyjnej. 2015;11(2):74-83

Trends Cardiovasc Med. 2013 Jul;23(5):153-64

Cardiol Res Pract. 2022 May 31;2022:5108389

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was approved by the ethics committees of Beijing Luhe Hospital, Capital Medical University and is in accordance with the declaration of Helsinki. Informed consent was obtained from all subjects. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

MeSH

Specialties

Copyright

© 2025. The Author(s).